85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

9 trials found

diseases per page:

Showing 1 to 9 of 9 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04564664 (ClinicalTrials.gov)	March 1, 2019	14/9/2020	High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis	High-flow OxygenTherapy During Exercise in Idiopathic Pulmonary Fibrosis: a Crossover Clinical Trial ...	Idiopathic Pulmonary Fibrosis	Drug: Oxygen	Parc de Salut Mar	Hospitales Universitarios Virgen del Rocío	Completed	18 Years	85 Years	All	10	N/A	Spain
2	NCT03688334 (ClinicalTrials.gov)	June 1, 2018	20/9/2018	Acute Effects of Oxygen Supplementation Among IPF Patients	Acute Effects of OxygenSupplementation During Exercise Among Patients With Idiopathic Pulmonary Fibr ...	Idiopathic Pulmonary Fibrosis	Drug: Oxygen 40 %;Drug: Medical air (sham O2)	George Papanicolaou Hospital	NULL	Unknown status	18 Years	80 Years	All	15	N/A	Greece
3	EUCTR2017-001276-27-GB (EUCTR)	21/08/2017	03/05/2017	A study to determine if GBT440 can increase the level of oxygenin the blood of people with Idiopathi ...	A Phase II open label study to evaluate the effect of GBT440 on hypoxemia in subjects with Idiopathi ...	Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 20.0;Level: PT;Classification code 10021240;Term ...	Product Name: GBT440 300 mg capsule Product Code: GBT440 Product Name: GBT440 300 mg tablet Product Code: ...	Global Blood Therapeutics Inc.	NULL	Not Recruiting			Female: yes Male: yes	32	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;United Kingdom
4	NCT02989168 (ClinicalTrials.gov)	November 2016	28/11/2016	Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygenat Re ...	A Phase II Open Label Study to Evaluate the Effect of GBT440 on Hypoxemia in Subjects With Idiopathi ...	Idiopathic Pulmonary Fibrosis;Hypoxemia	Drug: GBT440	Global Blood Therapeutics	NULL	Terminated	45 Years	85 Years	All	14	Phase 2	United States;United Kingdom
5	NCT02267655 (ClinicalTrials.gov)	May 2015	7/10/2014	3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hyper ...	An Exploratory, 3-Part, Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) on ...	Pulmonary Hypertension;Chronic Obstructive Pulmonary Disease;Idiopathic Pulmonary Fibrosis	Drug: inhaled Nitric Oxide - 30 mcg/kg IBW/hr;Drug: inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hr;Drug: ...	Bellerophon	NULL	Completed	40 Years	80 Years	All	8	Phase 1	Belgium
6	EUCTR2014-003423-21-BE (EUCTR)	29/09/2014	29/08/2014	Evaluation of impact of inhaled nitric oxide on pulmonary vessel blood volume measured by high resol ...	An Exploratory, Two-Part, Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) ...	Part 1: Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD) Par ...	Trade Name: INOmax 400ppm mol/mol inhalation gas Product Name: INO INN or Proposed INN: NITRIC OXIDE	Bellerophon Pulse Technologies LLC	NULL	Not Recruiting			Female: yes Male: yes		Phase 1;Phase 2	Belgium
7	NCT01214187 (ClinicalTrials.gov)	July 2011	30/9/2010	Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis	Phase II Study of Inhaled CO for the Treatment of Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis	Drug: inhaled carbon monoxide;Other: Oxygen	Brigham and Women's Hospital	National Heart, Lung, and Blood Institute (NHLBI);University of California, San Francisco;University ...	Completed	18 Years	85 Years	All	58	Phase 2	United States
8	JPRN-UMIN000005098	2011/02/01	18/02/2011	A randomized trial of ambulatory oxygenin patients with idiopathic pulmonary fibrosis and desaturati ...	A randomized trial of ambulatory oxygenin patients with idiopathic pulmonary fibrosis and desaturati ...	idiopathic pulmonary fibrosis	ambulatory oxygen ambulatory air	Department of Respiratory Medicine and Allergology, Kinki University School of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	20	Not selected	Japan
9	JPRN-UMIN000025256	2009/01/01	13/12/2016	Benefits of supplemental oxygen on exercise capacity and dyspnea in IPF patients	Benefits of supplemental oxygenon exercise capacity and dyspnea in IPF patients - Benefits of supple ...	idiopathic pulmonary fibrosis	oxygen gas air gas	Tosei General Hospital	NULL	Complete: follow-up complete	Not applicable	75years-old	Male and Female	106	Not applicable	Japan

First Previous1Next Last